Moreover, HO-1 upregulation contributes to chemoresistance to doxorubicin or gemcitabine in urothelial cancers and in cholangiocarcinoma cell lines and its inhibition or silencing is able to increase ROS production and cytotoxicity and inhibit tumor growth in vivo [83,84,85]. Here, HMOX1 is linked to cholangiocarcinoma.